Campomanes, Angelly R.
HRN: 10-53-48 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/22/2022
CEFUROXIME 500MG (TAB)
06/22/2022
06/29/2022
PO
500mg
Q12
Uti
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: No Wrong Route Wrong Route
Overall appropriateness: No Wrong Route